Pediatric AML: Clinical Trials

1 trial for Pediatric AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Pediatric AML: new trials by email Literature Review of Pediatric AML trials Research Report on Pediatric AML

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
Cladribine, G-CSF, Cytarabine - Leukemia, Monocytic, Acute, Pediatric AML
Phase 2 / Phase 3UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University432021-12-012023-07-27

Narrower conditions

Leukemia, Monocytic, Acute (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Cladribine (1)  ·  Cytarabine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Idarubicin (1)  ·  Mitoxantrone (1)  ·  Sorafenib (1)

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)

Countries

China (1)

Results publications

PMID 19242495, PMID 31279288